Angelman Syndrome Foundation (ASF): Call for Research Proposals

Priority given to projects focused on studying or correcting the heterozygous effect of non-UBE3A genes in deletion; the potential results of increasing UBE3A after therapies or for some subtypes of AS; the delivery of therapies and potential for improvement; and symptomatic therapies that impact the daily life of people with Angelman Syndrome and their families.

Funding: $100,000 per year for ½ years.

Please contact Research Authority if planning to submit- 10% overhead

https://www.angelman.org/research/call-for-proposals/